Variable | Group; no. (%) of patients* | |
---|---|---|
LSG n = 7 | LRYGB n = 4 | |
Sex | ||
Male | 1 (14) | 0 (0) |
Female | 6 (86) | 4 (100) |
Age, mean (SE), yr | 43.0 (8.6) | 54.5 (16.5) |
Baseline BMI, mean (SE) | 33.7 (0.44) | 33.2 (1.29) |
Preoperative oral hypoglycemic therapy | 6 (86) | 1 (25) |
Postoperative cessation | 3 (50) | 0 (0) |
Postoperative reduction | 3 (50) | 1 (100) |
Preoperative insulin therapy | 1 (14) | 3 (75)† |
Postoperative cessation | 1 (100) | 1 (33) |
Postoperative reduction | 0 (0) | 1 (33) |
Preoperative HbA1c level, mean (SE), % | 7.6 (1.09) | 7.7 (1.55) |
5-yr postoperative HbA1c level, mean (SE), % | 6.0 (0.006) | 6.7 (0.01) |
Postoperative diabetes status | ||
Complete remission | 3 (43) | 1 (25) |
Glycemic control | 3 (43) | 1 (25) |
No improvement | 0 (0) | 1 (25) |
Missing data | 1 (14) | 1 (25) |